Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Sredec AD_Sopharma_rights_3years_EN_26.01.2026.pdfNotification from "Sredec" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000001264

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 54 / 2026
Date of issue: 2026-01-29
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Sredec" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000001264
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Notification from "Sredec" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000001264
Annexes
File Description
Sredec AD_Sopharma_rights_3years_EN_26.01.2026.pdf
Sredec AD_Sopharma_rights_3years_EN_26.01.2026.pdf		 Notification from "Sredec" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000001264

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-01-29 Ognian Ivanov Donev Executive Director
20260129_084112_0399656394_Sredec_AD_Sopharma_rights_3years_EN_26.01.2026.pdf

Pobierz